Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

Registrieren

VRAX Virax Biolabs Group Ltd

1,32

0,03 (2,33%)

Nach Börsenschluss

Zuletzt aktualisiert: 00:55:26

Verzögert um 15 Minuten

Form D - Notice of Exempt Offering of Securities

Virax Biolabs (NASDAQ:VRAX)
Historical Stock Chart
Von Mai 2024 bis Jun 2024

Click Here for more Virax Biolabs Charts.

Virax Biolabs (NASDAQ:VRAX)
Historical Stock Chart
Von Jun 2023 bis Jun 2024

Click Here for more Virax Biolabs Charts.

News Virax Biolabs Group Ltd

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Dienstag 11 Juni 2024 (2 Wochen vor) • Edgar (US Regulatory)

Virax Biolabs Launches Portfolio of Immune Profiling Solutions Evaluating Adaptive Immunity in Post-Viral Syndromes at ESCMID Global 2024
Donnerstag 25 April 2024 (2 Monate vor) • PR Newswire (US)

Virax Biolabs to Participate at ESCMID Global 2024
Dienstag 16 April 2024 (2 Monate vor) • PR Newswire (US)

Virax Biolabs Announces Receipt of NASDAQ Notification Letter Regarding Minimum Bid Price Deficiency
Freitag 15 März 2024 (3 Monate vor) • PR Newswire (US)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Montag 22 Januar 2024 (5 Monate vor) • Edgar (US Regulatory)

Form 424B5 - Prospectus [Rule 424(b)(5)]
Montag 22 Januar 2024 (5 Monate vor) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Freitag 12 Januar 2024 (5 Monate vor) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Donnerstag 21 Dezember 2023 (6 Monate vor) • Edgar (US Regulatory)

Virax Biolabs Forges Strategic Research Collaboration with University of Manchester and the Northern Care Alliance Foundation Trust to Enhance Understanding of Immune Responses in COVID Patients
Donnerstag 21 Dezember 2023 (6 Monate vor) • PR Newswire (US)

Form 424B3 - Prospectus [Rule 424(b)(3)]
Mittwoch 20 Dezember 2023 (6 Monate vor) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Mittwoch 20 Dezember 2023 (6 Monate vor) • Edgar (US Regulatory)

Form 424B3 - Prospectus [Rule 424(b)(3)]
Mittwoch 20 Dezember 2023 (6 Monate vor) • Edgar (US Regulatory)

Weitere Virax Biolabs Group Ltd News-Artikel

VILOGIA DHLM Dhlm 1.5% 1...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen